in-person Meeting Information
Sanford Burnham Prebys Medical Discovery Institute has lifted their Covid-19 restrictions and are once again allowing IPCSG to hold their monthly meetings in person in their auditorium.
Livestreaming of the meetings will not be offered at this time, but may be resumed in the future. Video of the meetings are available on our IPCSG YouTube channel the week following the meetings.
https://www.youtube.com/@ProstateCancerSupport
As always, spouses/partners and caregivers are welcome and encouraged to attend!
For more information, you can call Bill at (619) 591-8670 or Gene at (619) 890-8447
Sanford Burnham Prebys Medical Discovery Institute (Building 12)
10905 Rd to the Cure, San Diego, CA 92121
(Press the button below, enter your location then press enter)
Dr. Rana McKay
Saturday October 21, 2023 10:00 AM PT
“Novel Therapeutic Strategies for Patients with Advanced Prostate Cancer”
Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate and testicular cancer.
Dr. McKay leads a multi-disciplinary prostate cancer clinic focused on delivering advanced cancer care through a coordinated team approach.
Dr. McKay will be highlighting recent FDA approved treatments for advanced prostate cancer. Additionally, she will discuss current novel treatments that are in development and clinical trials of the next generation treatments for prostate cancer.
Saturday September 16, 2023 10:00AM PT
Dean Hall - Swimming In Miracles
Dean is a licensed clinical therapist and coach with over 30 years of experience, an author and highly sought-after speaker, a two-time cancer survivor who experienced radical remission from leukemia and lymphoma, and a two-time world record-setting extreme distance swimmer.
He is the first person in history to swim the entire 187-mile length of Oregon’s longest river, the Willamette River, (which he did as an active cancer patient) in 2014, and Ireland’s longest river, the River Shannon (180 miles), in 2017.
IPCSG Roundtable
August 19, 2023 10:00 AM PT
Members of the IPCSG group will share stories about their journey with Prostate Cancer.
This is a great time to ask your questions from men who have gone through different treatments, their successes', difficulties and lessons learned.
A combined Q&A session will occur after all 3 have spoken.
This is your chance to get all your questions answered by men who have
"been there, done that".
See it, Treat it The Telix Pipeline
July 15, 2023, 10:00AM PT
Mary Hames, PhD, EMBA, holds a BS and MS in Chemistry, an interdisciplinary PhD in Biochemistry, Genetics, and Chemical Engineering from the University of Alabama Huntsville and an Executive MBA from Kennesaw State.
She is now the US Medical Director for Telix pharmaceuticals, and manages the US Field Medical Team which functions to educate US HCP’s on Telix’s commercially approved products as well as their pipeline diagnostics and therapeutics.
Laser Focal Therapy and Genomic Testing
June 17, 2023, 10:00AM PT
Bernadette M. Greenwood Chief Research Officer at HALO Diagnostics will be presenting the history, updates and results of the focal therapy clinical trial NCT 02243033 (LINK) that she and her team have been conducting.
She will be joined by Dr. Aaron Harman, who will share some real-life scenarios as case studies.
Decipher (Veracyte Labs SD) will also be on-hand to provide information and answers regarding tissue-based genomics.
May 20, 2023, 10:00AM PT
Our May meeting will be a double header covering 2 very important and timely subjects:
- Provenge Immunotherapy - is a personalized immunotherapy that activates the immune system to help fight advanced prostate cancer and has been proven to help certain men live longer. It works differently from other cancer treatments, such as chemotherapy or hormone therapy.
- Sparrow Search - is a patient-friendly search engine that allows patients to directly search for and match to clinical trials. Patients who match to clinical trials are connected with clinical research sites, thereby increasing the pool of potential study candidates and expediting the recruitment process.
april 15, 2023, 10:00AM PT
The Medical Journey of a Prostate Cancer Patient
Dr. Richard Lam will be our speaking at the April 15 IPCSG meeting. Dr. Lam is a double board-certified internist and oncologist, who has been specializing in the treatment of prostate cancer since 2001 at Prostate Oncology Specialists in Marina del Rey, California.
HIs presentation will include updates on the latest trials, testing and treatment options available for prostate cancer patients. As always, his presentations are very informative and presented in an easily understood format. He also brings a great wit with a touch of humor.
March 18, 2023
Dr. Paul Dato
Director, Genesis Healthcare
Prostate Cancer Tests
Dr. Paul Dato is a urologist and currently serves as Director for Medical Quality and Director of the Prostate Cancer Center for Genesis healthcare.
Dr. Dato will be discussing New Prostate Cancer Tests…and some Old Ones
February 18, 2023
IPCSG Roundtable
Members of the IPCSG group will share stories about their journey with Prostate Cancer, then YOU will have a chance to ask questions about your specific situation.
- Darrell Dixon will tell us how he has coped with prostate cancer for many years, including recent developments.
- Dan Peddie will share his journey, including radiation, Lupron, Zytiga, Xtandi and Lynparza, challenges with doctors and current decisions.
- The third part of our meeting will be an open mic session, focusing on attendees who are undecided about what to do next. A panel of experienced members including Gene Van Vleet, Bill Lewis, and Aaron Lamb will provide some answers, and the audience will provide more suggestions.
- Fourth, we will invite members to break into additional groups to ask questions on radiation, surgery, active surveillance, hormone therapy, and the rest of those who are undecided about what to do next.
January 21, 2023
Dr. A. J. Mundt MD,
UCSD Radiation Oncology
Updates on Radiation Oncology
Arno J. Mundt, MD, FACRO, FASTRO
- Radiation Oncologist and Professor and Chair of Radiation Medicine and Applied Sciences
- Dr. Mundt will be introducing the other speakers and giving an introductory overview of radiation oncology as it relates to prostate cancer.
Brent Rose, MD
- Radiation Oncologist and Assistant Professor of Radiation Medicine and Applied Sciences
- Dr. Rose will give his perspectives on treating prostate cancer with radiotherapy.
Tyler Seibert, MD, PhD
- Radiation Oncologist
- Dr. Seibert will speak about advanced imaging.
Carl Rossi MD
- Medical Director of the California Proton Therapy Center
- Dr. Rossi will speak about Prostate Cancer Treatment using Proton Therapy.
November 19, 2022
Mitchell Kamrava, MD, "High and Low Dose Rate Brachytherapy"
Dr. Kamrava is a Radiation Oncology Specialist in West Hollywood, CA. He is affiliated with medical facilities Cedars - Sinai Medical Center and Ronald Reagan UCLA Medical Center. He specializes in High Dose Rate Brachytherapy, IMRT (Intensity-Modulated Radiation Therapy), Image Guided Radiation Therapy, Intensity Modulated Radiation Therapy, Internal Radiation Therapy, Interventional Oncology, and various cancers.
October 15, 2022
"Surviving [Aggressive] Prostate Cancer," by Dr. William Lewis, Ph.D.
Lessons learned from 7 years of living with Gleason 9 cancer that metastasized to a hundred places in the bone. Options for anyone living with prostate cancer, from active surveillance to focal treatments, to radiation or surgery, and on to new treatments. Suggestions for thriving while minimizing cancer growth. Nuggets from summarizing IPCSG monthly meetings for six years. Preview of a book in progress about prostate cancer.
After the talk, a light lunch will be served outside the auditorium, in celebration of returning to in-person meetings after 2-1/2 years of online-only meetings.
September 17, 2022
Dr. T. Mike Hsieh - Male Sexual Dysfunction
Dr. Hsieh is a Professor of Urology and Director, UCSD Men’s Health Center.
He specializes in male fertility and men’s health. He treats men with sexual dysfunction including low testosterone, erectile dysfunction, and Peyronie's disease. He also treats male infertility including men with ejaculatory disorder, hormone imbalance, sperm production impairment, cancer, and genetic causes of infertility.
In collaboration with doctors at Moores Cancer Center, he focuses on enabling male patients with cancer to preserve their fertility options before cancer therapy. He also helps cancer survivors preserve or regain their sexual function after they receive cancer treatment that has sexual side effects.
August 20, 2022
Robert Hoffman MD - Next-Generation Cancer Treatment Using a Nontoxic Metabolic Therapy
Robert Hoffman, Professor Emeritus in the UCSD Dept. Of Surgery, will teach us from his fifty years of research, "How to Starve Cancer Naturally." He will be joined by Mark Simon, CN, of the Nutritional Oncology Research Institute.
Dr. Hoffman's recommendations focus on starving cancer by limiting its access to the amino acid Methionine through diet and a methioninase supplement.
His website is howtostarvecancernaturally.com.
Email: meishale@gmail.com
His discussion will include:
- A Review of Metabolic Approaches to Cancer Therapy
- Cancer Methionine Dependence and "Addiction" of Cancer Cells
- Safety and Efficacy of Dietary Methionine Restriction
- Foods Highest and Lowest in Methionine
- Enzymatic Methionine Degradation with Methioninase
- Sensitization of Cancer Cells to Chemotherapy by Methionine Restriction
- Health and Anti-aging Benefits of Methionine Restriction
- High-resolution Tumor Imaging with Methionine-PET Scanning
July 16, 2022
IPCSG Roundtable
Three members of the IPCSG group will share stories about their journey with Prostate Cancer.
- Patrick M. Diagnosed with Gleason 9 in 2018. Had prostate radiation, then follow-up treatments to spine, femur and recently pubic bone. On Zytiga without Lupron. PSA drifting down since radiation in February, now at 2.2.
- Mike D. Diagnosed with Gleason 9 in 2019, with multiple pelvic node tumors. Pelvic radiation brought a clear Axumin scan by Nov. 2021, but now his PSA is rising. Axumin can't find it. Will obtain PSMA scan results before the meeting.
- Bob S. Had proton therapy 3 years ago. Recent PSA's 1.2 to 1.5 to 1.7. MRI w/contrast showed 3.7 mm lesion in pelvis. None seen elsewhere. Will obtain PSMA scan results before the meeting.
This is your chance to get all your questions answered by men who have
"been there, done that".
June 18, 2022
Mary Hames PhD, EMBA - GA68 PSMA
Dr. Hames holds a BS and MS in Chemistry, an interdisciplinary PhD in Biochemistry, Genetics, and Chemical Engineering from the University of Alabama Huntsville and an Executive MBA from Kennesaw State.
Dr. Hames is now the US Medical Director for Telix pharmaceuticals, and manages the US Field Medical Team which functions to educate US HCP’s on Telix’s commercially approved products as well as their pipeline diagnostics and therapeutics.
Due to some of the content that was presented by Dr. Hames, only a PDF of the presentation is available. To view or download the presentation, click the button below
May 21, 2022
Dr. Tanya Dorff - Immunotherapy
Dr. Tanya Dorff is a medical oncologist who serves as associate clinical professor in the Department of Medical Oncology & Therapeutics Research and the Head of the Genitourinary Cancers Program at City of Hope, a research and treatment center for cancer based in Duarte, California.
Dr. Dorff’s research interests in prostate cancer range from clinical trials in PSA-recurrent prostate cancer to the role of fasting in chemotherapy tolerability to CAR T cells that are primed to target prostate cancer tissue.
April 16, 2022
Dr. Richard Lam MD,
Prostate Oncology Specialists
2022 Update on Prostate Cancer
A double board-certified internist and oncologist, Richard Lam, MD, has been specializing full time at Prostate Oncology Specialists in the treatment of prostate cancer since 2001.
Dr. Lam will be discussing the latest news about Prostate Cancer, treatments and clinical trials.
As always, his presentations will be very informative and presented in an easily understood format. He also brings a great wit with a touch of humor.